Biofil Chemicals & Pharmaceuticals Ltd

₹31.82▲ +0.98%29 Sept

📊 Stock Analysis

Market Data

Market Cap₹51.78 Cr.

52W High₹46.82

Current Price₹31.82

52W Low₹25.6

Down from 52W High32 %

Face Value₹10

Performance

ROCE3.34 %

ROE2.23 %

EPS (TTM)₹0.07

EPS Prev Qtr₹0.13

EPS Last Year₹0.05

EBITDA Qtr₹0.07 Cr.

Book Value₹13

Financial Health

Debt/Equity0.14

Debt/Profit6.29

Total Assets₹42.85 Cr.

Promoter Holding46.79 %

Earning Power1.19 %

Valuation

Stock P/E106.07

Industry P/E33.3

Price to Book2.4

Price to Sales1.51

Graham Number₹9.46

Key Metrics

Face Value

₹10

About Biofil Chemicals & Pharmaceuticals Ltd

Healthcare · Pharmaceuticals

Biofil Chemicals & Pharmaceuticals Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹10. Market cap ₹51.78 Cr.

Price Chart

Peer Comparison

Name	CMP	P/E	Market Cap	Div Yield	NP Qtr	Qtr Profit Var%	Sales Qtr	Qtr Sales Var%	ROCE%	Debt/Eq
Sun Pharmaceutical Industries Ltd	-	36.9	₹4,46,276.3 Cr	0.86%	₹12,172.7 Cr	-	₹59,910.52 Cr	-	18.72%	0.05
Divis Laboratories Ltd	-	85.97	₹2,51,531.48 Cr	0.32%	₹2,925 Cr	-	₹11,230 Cr	-	23.04%	0
Torrent Pharmaceuticals Ltd	-	78.4	₹1,86,956.51 Cr	0.77%	₹2,156 Cr	-	₹15,723 Cr	-	15.1%	1.76
Zydus Lifesciences Ltd	-	26.64	₹1,19,221.66 Cr	0.08%	₹4,492.2 Cr	-	₹28,591.7 Cr	-	16.76%	0.43
Cipla Ltd	-	33.13	₹1,11,725.01 Cr	0.94%	₹3,364.84 Cr	-	₹28,324.4 Cr	-	13.24%	0.01
Laurus Labs Ltd	-	98.01	₹1,07,271.96 Cr	0.06%	₹1,090.76 Cr	-	₹7,269.64 Cr	-	20.79%	0.45
Mankind Pharma Ltd	-	51.42	₹1,05,107.48 Cr	0.04%	₹2,067.57 Cr	-	₹14,737.88 Cr	-	13.95%	0.38
Dr Reddys Laboratories Ltd	-	32.31	₹1,04,334.48 Cr	0.64%	₹3,183.3 Cr	-	₹33,227.9 Cr	-	10.05%	0.17
Aurobindo Pharma Ltd	-	26.61	₹97,986.86 Cr	0.23%	₹3,710.8 Cr	-	₹34,935.29 Cr	-	12.75%	0.2
Lupin Ltd	-	16.63	₹94,189.9 Cr	0.87%	₹5,550.99 Cr	-	₹29,966.58 Cr	-	27.95%	0.26
Glenmark Pharmaceuticals Ltd	-	37.59	₹67,587.09 Cr	0.1%	₹1,797.81 Cr	-	₹17,736.56 Cr	-	24.78%	0.25
Alkem Laboratories Ltd	-	29.02	₹62,609.02 Cr	1.01%	₹2,206.3 Cr	-	₹15,081.28 Cr	-	19.75%	0.12
Biocon Ltd	-	111.18	₹61,602.44 Cr	0.13%	₹416.4 Cr	-	₹17,321.1 Cr	-	2.87%	0.43
Abbott India Ltd	-	35.88	₹57,939.73 Cr	1.74%	₹1,614.68 Cr	-	₹7,004.38 Cr	-	45.73%	0
Gland Pharma Ltd	-	43.62	₹49,299.85 Cr	0.67%	₹1,128.8 Cr	-	₹6,725.3 Cr	-	15.21%	0.02
Ipca Laboratories Ltd	-	36.55	₹49,280.78 Cr	0.31%	₹1,379.76 Cr	-	₹10,125.58 Cr	-	21.48%	0.09
Anthem Biosciences Ltd	-	85	₹49,084.9 Cr	0.23%	₹575.95 Cr	-	₹2,002.34 Cr	-	25.5%	0.02
Glaxosmithkline Pharmaceuticals Ltd	-	44.95	₹47,217.7 Cr	2.05%	₹1,068.15 Cr	-	₹3,954.94 Cr	-	64.07%	0
Ajanta Pharma Ltd	-	39.17	₹44,452.1 Cr	0.79%	₹1,134.88 Cr	-	₹5,776.17 Cr	-	31.81%	0.05
J B Chemicals & Pharmaceuticals Ltd	-	53.3	₹38,730.77 Cr	0.39%	₹709.46 Cr	-	₹4,147.79 Cr	-	23.03%	0

Quarterly Results

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	13.54	0.86	7.57	12.35
↳ QoQ Growth	-	-93.6%	+780.2%	+63.1%
Expenses	13.49	0.83	7.21	12.28
Operating Profit	0.05	0.03	0.36	0.07
OPM %	0.37%	3.49%	4.76%	0.57%
Other Income	0.06	0.08	0.11	0.06
Interest	0	0	0	0
Depreciation	0.07	0.07	0.07	0.07
EBITDA	0.12	0.1	0.43	0.14
EBITDA Margin %	0.89%	11.63%	5.68%	1.13%
Profit Before Tax	0.11	0.11	0.47	0.13
Tax %	27.27%	27.27%	55.32%	23.08%
Net Profit	0.08	0.08	0.21	0.11
↳ QoQ Growth	-	0.0%	+162.5%	-47.6%
EPS	0.05	0.05	0.13	0.07

Balance Sheet

	Mar 2025	Mar 2026
Equity Capital	16.2738	16.27
Reserves	2.5076	5.29
Borrowings	0.47	3.02
Other Liabilities	31.71	18.27
Total Liabilities	50.9604	42.85
Fixed Assets	8.3447	6.94
CWIP	0	0
Investments	0	0
Other Assets	42.62	35.91
Total Assets	50.9604	42.85

Cash Flows

	Mar 2025
Cash from Operating Activity	-1.9237
Cash from Investing Activity	-0.1001
Cash from Financing Activity	-0.0045
Net Cash Flow	-2.0283

Shareholding Pattern

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters %	46.79%	46.79%	46.79%	46.79%
FIIs %	0%	0%	0%	0%
DIIs %	0.08%	0.08%	0.08%	0.08%
Public %	38.23%	38.27%	38.4%	38.63%
No. of Shareholders	25,196	24,825	25,356	24,999

Major Shareholders (>1%)

As of 2026-06-30View all shareholders →

Tools